Stock Earnings

Question 1

What are Alterity Therapeutics Limited's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Alterity Therapeutics Limited has a total asset of $0, Net loss of $-12

Question 2

What are the key financial ratios for PRNAF?

Accepted Answer

Alterity Therapeutics Limited's Current ratio is 0, has a Net margin is 0, sales per share of $0.

Question 3

How is Alterity Therapeutics Limited's revenue broken down by segment or geography?

Accepted Answer

Currently Alterity Therapeutics Limited data is not available.

Question 4

Is Alterity Therapeutics Limited profitable?

Accepted Answer

no, according to the latest financial statements, Alterity Therapeutics Limited has a net loss of $-12

Question 5

Does Alterity Therapeutics Limited have any liabilities?

Accepted Answer

no, Alterity Therapeutics Limited has liability of 0

Question 6

How many outstanding shares for Alterity Therapeutics Limited?

Accepted Answer

Alterity Therapeutics Limited has a total outstanding shares of 0

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
Revenue	1	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	7	5	4	5	5	7
Research & Development	16	14	18	13	14	12
Operating Expenses	17	14	19	14	15	15
Other Non Operating Income (Expenses)	2	2	0	0	0	0
Pretax Income	-14	-12	-19	-13	-12	-15
Income Tax Expense	0	0	0	0	0	0
Net Income	-14	-12	-19	-13	-12	-15
Net Income Growth	-26%	-37%	46%	8%	-20%	15%
Shares Outstanding (Diluted)	10,684.27	6,396.92	3,648.87	2,427.84	2,405.99	1,696.87
Shares Change (YoY)	109%	75%	50%	1%	42%	90%
EPS (Diluted)	0	0	0	0	0	0
EPS Growth	-60%	-63%	-9%	8%	-41%	-40%
Free Cash Flow	-22	-11	-12	-20	-12	-17
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	-1,600%	0%	0%	0%	0%	0%
Profit Margin	-1,400%	0%	0%	0%	0%	0%
Free Cash Flow Margin	-2,200%	0%	0%	0%	0%	0%
EBITDA	-16	-14	-19	-14	-15	-15
EBITDA Margin	-1,600%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-16	-14	-19	-14	-15	-15
EBIT Margin	-1,600%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Alterity Therapeutics Limited (PRNAF) Financial